141713-91-9

Basic information

• Product Name: {(S)-1-[(S)-1-((1S,2S,4R)-2-Hydroxy-1-isobutyl-4-isobutylcarbamoyl-heptylcarbamoyl)-pentylcarbamoyl]-2-naphthalen-1-yl-ethyl}-carbamic acid benzyl ester
• CAS NO: 141713-91-9
• Molecular Weight: 730.988
• Mol File: 141713-91-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {(S)-1-[(S)-1-((1S,2S,4R)-2-Hydroxy-1-isobutyl-4-isobutylcarbamoyl-heptylcarbamoyl)-pentylcarbamoyl]-2-naphthalen-1-yl-ethyl}-carbamic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: {(S)-1-[(S)-1-((1S,2S,4R)-2-Hydroxy-1-isobutyl-4-isobutylcarbamoyl-heptylcarbamoyl)-pentylcarbamoyl]-2-naphthalen-1-yl-ethyl}-carbamic acid benzyl ester(141713-91-9)
• EPA Substance Registry System: {(S)-1-[(S)-1-((1S,2S,4R)-2-Hydroxy-1-isobutyl-4-isobutylcarbamoyl-heptylcarbamoyl)-pentylcarbamoyl]-2-naphthalen-1-yl-ethyl}-carbamic acid benzyl ester(141713-91-9)

Safety Data

• Hazardous Substances Data: 141713-91-9(Hazardous Substances Data)

Upstream product

• 141714-15-0 (S)-methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-(naphthalen-1-yl)propanamido)hexanoate 
• 118865-55-7 (4S,5S)-4-Isobutyl-5-((E)-2-isobutylcarbamoyl-pent-1-enyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid benzyl ester 
• 118741-21-2 (4S,5S)-5-((E)-2-Ethoxycarbonyl-pent-1-enyl)-4-isobutyl-2,2-dimethyl-oxazolidine-3-carboxylic acid benzyl ester 
• 118741-22-3 (4S,5S)-5-((E)-2-Carboxy-pent-1-enyl)-4-isobutyl-2,2-dimethyl-oxazolidine-3-carboxylic acid benzyl ester 
• 65365-15-3 2S-2-benzyloxycarbonylamino-2-(naphth-1-yl)methyl-acetic acid 
• 55516-54-6 L-1-naphthylalanine 
• 116993-95-4 (4S,5S)-3-Benzyloxycarbonyl-5-formyl-4-isobutyl-2,2-dimethyloxazolidine 
• 59759-78-3 2-benzoylamino-3-naphthalen-1-yl-propionic acid 
• 35051-49-1 2-diethoxyphosphoryl-pentanoic acid ethyl ester 
• 118586-12-2 N--L-norleucine 

Relevant articles and documents

Renin inhibitors. I. Synthesis and structure-activity relationship of transition-state inhibitors containing homostatine analogues at the scissile bond

The synthesis and structure-activity relationships of transition-state renin inhibitors containing the homostatine analogues at the scissile bond are described. These inhibitors incorporate the amino acid side chains corresponding to positions 7-12 (Psub